ARS Pharmaceuticals Files 8-K Report
Ticker: SPRY · Form: 8-K · Filed: Mar 5, 2025 · CIK: 1671858
| Field | Detail |
|---|---|
| Company | Ars Pharmaceuticals, Inc. (SPRY) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Disclosure
TL;DR
ARS Pharma filed an 8-K on 3/5/25. Standard disclosure.
AI Summary
On March 5, 2025, ARS Pharmaceuticals, Inc. filed an 8-K report. The filing pertains to 'Other Events' and was submitted on the same date. The company, formerly known as Silverback Therapeutics, Inc. until April 12, 2016, is incorporated in Delaware and headquartered in San Diego, California.
Why It Matters
This filing indicates a routine update or event disclosure by ARS Pharmaceuticals, Inc. to the SEC, which may contain information relevant to investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not appear to disclose significant new risks or material adverse information.
Key Numbers
- 001-39756 — SEC File Number (Identifies the company's filing with the SEC.)
- 81-1489190 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- ARS Pharmaceuticals, Inc. (company) — Registrant
- Silverback Therapeutics, Inc. (company) — Former company name
- 11682 El Camino Real, Suite 120 (location) — Principal executive offices address
- San Diego, California (location) — Principal executive offices city and state
- March 5, 2025 (date) — Date of report and earliest event
FAQ
What specific 'Other Event' is being reported by ARS Pharmaceuticals, Inc. in this 8-K filing?
The provided text does not specify the exact 'Other Event'; it only indicates that the filing pertains to this item category.
When was ARS Pharmaceuticals, Inc. formerly known as Silverback Therapeutics, Inc.?
ARS Pharmaceuticals, Inc. was formerly known as Silverback Therapeutics, Inc. until April 12, 2016.
What is the principal executive office address for ARS Pharmaceuticals, Inc.?
The principal executive office address is 11682 El Camino Real, Suite 120, San Diego, California, 92130.
What is the SEC file number for ARS Pharmaceuticals, Inc.?
The SEC file number for ARS Pharmaceuticals, Inc. is 001-39756.
On what date was this 8-K report filed?
This 8-K report was filed on March 5, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 5, 2025 regarding ARS Pharmaceuticals, Inc. (SPRY).